MORGAN STANLEY PLC/CALL/BRISTOL-MYERS SQUIBB/80/0.1/20.12.24

MORGAN STANLEY PLC/CALL/BRISTOL-MYERS SQUIBB/80/0.1/20.12.24 Share Price

DE000ME66BM6

Market Closed - Börse Stuttgart 12:52:56 01/06/2024 am IST
0.013 ^EUR	-.--%

3 months

-56.67%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart BRISTOL-MYERS SQUIBB COMPANY

Chart MORGAN STANLEY PLC/CALL/BRISTOL-MYERS SQUIBB/80/0.1/20.12.24

Latest news about BRISTOL-MYERS SQUIBB COMPANY

Pre-surgery treatment with Bristol Myers combination therapy leads to better skin cancer outcomes	05:30pm	RE
GSK blood cancer drug nearly halves risk of death in late-stage trial	05:30pm	RE
KRAZATI (adagrasib) Demonstrated Statistically Significant Improvement in Progression-Free Survival in Patients with Pretreated Locally Advanced or Metastatic KRASG12C-Mutated Non-Small Cell Lung Cancer	01/06	BU
Bristol-Myers Squibb Says Breyanzi Gets FDA Approval as CAR T Cell Therapy for Mantle Cell Lymphoma	30/05	MT

More news

Quotes 5-day view

Date	Price	Change
31/24/31	0.013	-.--%
30/24/30	0.013	-.--%
29/24/29	0.013	-.--%
28/24/28	0.013	+8.33%
27/24/27	0.012	-7.69%

Delayed Quote Börse Stuttgart

Last update May 01, 2024 at 12:52 am IST

More quotes

Static data

Product type	Plain-Vanilla-Warrants
Buy / Sell	CALL
Underlying	BRISTOL-MYERS SQUIBB COMPANY
Issuer	Morgan Stanley
WKN	ME66BM
ISIN	DE000ME66BM6
Date issued	02/01/2024
Strike	80 $
Maturity	20/12/2024 (201 Days)
Parity	10 : 1
Emission price	0.07 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	0.039 €
Lowest since issue	0.01 €
Spread	0.027 €
Spread %	67.50%

Company Profile

Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques. The United States account for 70.1% of net sales.

Sector

More about the company

Ratings for Bristol-Myers Squibb Company

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Consensus: Bristol-Myers Squibb Company

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

41.09 USD

Average target price

53.19 USD

Spread / Average Target

+29.46%

Consensus